4.6 Article

Integrative Analysis Identified MCT4 as an Independent Prognostic Factor for Bladder Cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Radiology, Nuclear Medicine & Medical Imaging

VI-RADSfor Bladder Cancer: Current Applications and Future Developments

Valeria Panebianco et al.

Summary: This article reviews the current applications and future perspectives of the Vesical Imaging Reporting and Data System (VI-RADS) in bladder cancer (BCa). It discusses the role of MRI in BCa staging and treatment monitoring, as well as the clinical implications and future applications of the scoring system.

JOURNAL OF MAGNETIC RESONANCE IMAGING (2022)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Andrology

Systemic combining inflammatory score (SCIS): a new score for prediction of oncologic outcomes in patients with high-risk non-muscle-invasive urothelial bladder cancer

Matteo Ferro et al.

Summary: This study aimed to develop a score using serum inflammatory variables to better predict cancer outcomes in high-risk non-muscle invasive bladder cancer patients. Results showed that a higher systemic combined inflammatory score was independently predictive of recurrence, cancer-specific mortality, and overall mortality, but not associated with progression.

TRANSLATIONAL ANDROLOGY AND UROLOGY (2021)

Review Health Care Sciences & Services

Liquid Biopsy Biomarkers in Urine: A Route towards Molecular Diagnosis and Personalized Medicine of Bladder Cancer

Matteo Ferro et al.

Summary: Bladder cancer is characterized by high incidence and recurrence rates, as well as genomic instability and elevated mutation degree. Current diagnosis, prognosis and disease surveillance often involve cystoscopy combined with cytology, which may cause side effects and economic burden. Liquid biopsy, a promising tool investigated over the last decade, is essential for non-invasive, sensitive, fast and inexpensive biomarkers for clinical management of BC patients. Liquid biopsy may play a key role in precision medicine for treatment selection and real-time monitoring of therapeutic effects, with various urinary biomarkers proposed for BC detection, prognosis, surveillance and response to therapy.

JOURNAL OF PERSONALIZED MEDICINE (2021)

Article Oncology

Bladder Cancer. Version 3.2020

Thomas W. Flaig et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)

Article Oncology

Prediction of recurrence and progression in patients with T1G3 bladder cancer by gene expression of circulating tumor cells

Amira Awadalla et al.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2020)

Article Biochemistry & Molecular Biology

Comprehensive Integration of Single-Cell Data

Tim Stuart et al.

Article Urology & Nephrology

Late Recurrence of Bladder Cancer following Radical Cystectomy: Characteristics and Outcomes

Sang Hyun Yoo et al.

UROLOGIA INTERNATIONALIS (2019)

Article Biotechnology & Applied Microbiology

Dimensionality reduction for visualizing single-cell data using UMAP

Etienne Becht et al.

NATURE BIOTECHNOLOGY (2019)

Article Urology & Nephrology

Can urinary biomarkers replace cystoscopy?

Moritz Maas et al.

WORLD JOURNAL OF UROLOGY (2019)

Article Biotechnology & Applied Microbiology

Integrating single-cell transcriptomic data across different conditions, technologies, and species

Andrew Butler et al.

NATURE BIOTECHNOLOGY (2018)

Article Oncology

Selective Inhibition of the Lactate Transporter MCT4 Reduces Growth of Invasive Bladder Cancer

Tilman Todenhoefer et al.

MOLECULAR CANCER THERAPEUTICS (2018)

Review Biochemistry & Molecular Biology

Liquid Biopsy Biomarkers in Bladder Cancer: A Current Need for Patient Diagnosis and Monitoring

Iris Lodewijk et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Article Biochemical Research Methods

Orchestrating high-throughput genomic analysis with Bioconductor

Wolfgang Huber et al.

NATURE METHODS (2015)

Review Oncology

Warburg Effect or Reverse Warburg Effect? A Review of Cancer Metabolism

Xiao Dong Xu et al.

ONCOLOGY RESEARCH AND TREATMENT (2015)

Article Biochemistry & Molecular Biology

CD147 and MCT1-potential partners in bladder cancer aggressiveness and cisplatin resistance

Julieta Afonso et al.

MOLECULAR CARCINOGENESIS (2015)

Review Biochemistry & Molecular Biology

Tumor glycolysis as a target for cancer therapy: progress and prospects

Shanmugasundaram Ganapathy-Kanniappan et al.

MOLECULAR CANCER (2013)

Article Physiology

Monocarboxylic Acid Transport

Andrew P. Halestrap

COMPREHENSIVE PHYSIOLOGY (2013)

Review Biochemistry & Molecular Biology

Hallmarks of Cancer: The Next Generation

Douglas Hanahan et al.

Review Cell Biology

Tumor suppressors and cell metabolism: a recipe for cancer growth

Russell G. Jones et al.

GENES & DEVELOPMENT (2009)

Review Multidisciplinary Sciences

Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

Matthew G. Vander Heiden et al.

SCIENCE (2009)

Article Physiology

The SLC16 gene family -: from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond

AP Halestrap et al.

PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2004)